Gsa Capital Partners LLP Electro Core, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$0.93 - $1.18 $196,191 - $248,931	-210,959 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$1.19 - $2.06 $78,607 - $136,077	66,057 Added 45.59%	210,959 $251,000
Q1 2021 May 10, 2021	SELL	$1.62 - $3.05 $13,612 - $25,629	-8,403 Reduced 5.48%	144,902 $298,000
Q4 2020 Feb 03, 2021	BUY	$1.44 - $1.98 $164,730 - $226,504	114,396 Added 294.01%	153,305 $239,000
Q3 2020 Nov 06, 2020	BUY	$0.8 - $2.33 $31,127 - $90,657	38,909 New	38,909 $67,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $523M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.